Search Within

Ellen Marlese Basu

  1. "GSK Faculty"
Formats
  1. Meeting Abstract (35)
  2. Journal Article (29)
Groups
  1. Center for Molecular Imaging and Biotechnology (CMIB) (64)
  2. GSK Faculty (64)
  3. Neuroblastoma Service (64)
  4. Pediatrics, Department of (64)
  5. Tow Center for Developmental Oncology (TCDO) (63)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (62)

More Groups

People
  1. Shakeel Modak (63)
  2. Brian Kushner (61)
  3. Nai-Kong Cheung (61)
  4. Stephen Roberts (56)
  5. Kim Kramer (34)
  6. Suzanne Wolden (20)

More People

Years
  1. 2025 (1)
  2. 2024 (4)
  3. 2023 (8)
  4. 2022 (3)
  5. 2021 (5)
  6. 2020 (5)

More Years

Publications
  1. Pediatric Blood and Cancer (22)
  2. Journal of Clinical Oncology (10)
  3. International Journal of Radiation Oncology, Biology, Physics (5)
  4. Cancer (4)
  5. International Journal of Cancer (4)
  6. Neuro-Oncology (3)

More Publications

Publishers
  1. Wiley Periodicals, Inc (22)
  2. American Society of Clinical Oncology (10)
  3. Elsevier Inc. (5)
  4. John Wiley & Sons (4)
  5. Wiley Blackwell (4)
  6. American Association for Cancer Research (3)

More Publishers

Results (64)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety and efficacy of intraventricular (131)I-labeled monoclonal antibody 8H9 targeting the surface glycoprotein B7-H3
    Meeting Abstract

    Kramer, K.; Kushner, B.; Modak, S.; Taskar, N. P.; Tomlinson, U.; Donzelli, M.; Wolden, S.; Zanzonico, P.; Humm, J.; Haque, S.; more...
    Neuro-Oncology (2018)

    Fulltext@MSK | Save
  • Safety and efficacy of intraventricular (131)I-labeled monoclonal antibody 8H9 targeting the surface glycoprotein B7-H3 in patients with CNS/LM disease
    Meeting Abstract

    Kramer, K.; Kushner, B.; Modak, S.; Pandit-Taskar, N.; Tomlinson, U.; Donzelli, M.; Wolden, S.; Zanzonico, P.; Humm, J.; Haque, S.; more...
    Neuro-Oncology (2017)

    Fulltext@MSK | Save
  • Safety and efficacy of intraventricular (131)I-labeled monoclonal antibody 8H9 targeting the surface glycoprotein B7-H3 in patients with CNS/LM disease
    Meeting Abstract

    Kramer, K.; Kushner, B.; Modak, S.; Pandit-Taskar, N.; Tomlinson, U.; Donzelli, M.; Wolden, S.; Zanzonico, P.; Humm, J.; Haque, S.; more...
    Neuro-Oncology (2017)

    Fulltext@MSK | Save
  • Local control with reduced-dose radiation therapy for high-risk neuroblastoma: Results from a prospective trial
    Meeting Abstract

    Casey, D. L.; Kushner, B.; Cheung, N. K.; Modak, S.; La Quaglia, M. P.; Basu, E.; Roberts, S.; Wolden, S. L.
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save
  • MYCN-amplified stage 2/3 neuroblastoma: Excellent survival in the era of anti-G(D2) immunotherapy
    Journal Article

    Kushner, B. H.; LaQuaglia, M. P.; Modak, S.; Wolden, S. L.; Basu, E. M.; Roberts, S. S.; Kramer, K.; Yataghene, K.; Cheung, I. Y.; Cheung, N. V.
    Oncotarget (2017)

    Fulltext@MSK | Save
  • Phase I trial of anti-GD2 monoclonal antibody hu3F8 plus GM-CSF: Impact of body weight, immunogenicity and anti-GD2 response on pharmacokinetics and survival
    Journal Article

    Cheung, I. Y.; Kushner, B. H.; Modak, S.; Basu, E. M.; Roberts, S. S.; Cheung, N. K. V.
    OncoImmunology (2017)

    Fulltext@MSK | Save
  • Combination of bevacizumab, irinotecan, and temozolomide for refractory or relapsed neuroblastoma: Results of a phase II study
    Journal Article

    Modak, S.; Kushner, B. H.; Basu, E.; Roberts, S. S.; Cheung, N. K. V.
    Pediatric Blood and Cancer (2017)

    Fulltext@MSK | Save
  • A phase I/Ib trial targeting the Pi3k/Akt pathway using perifosine: Long-term progression-free survival of patients with resistant neuroblastoma
    Journal Article

    Kushner, B. H.; Cheung, N. K. V.; Modak, S.; Becher, O. J.; Basu, E. M.; Roberts, S. S.; Kramer, K.; Dunkel, I. J.
    International Journal of Cancer (2017)

    Fulltext@MSK | Save
  • Phase II study of the combination of bevacizumab plus irinotecan and temozolomide for relapsed or refractory neuroblastoma (NB)
    Meeting Abstract

    Modak, S.; Kushner, B. H.; Kramer, K.; Leyco, S.; Basu, E. M.; Roberts, S. S.; Cheung, N. K. V.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Event-free survival (EFS) and overall survival (OS) of MYCN-amplified stage 2/3 neuroblastoma with or without autologous stem-cell transplantation (ASCT)
    Meeting Abstract

    Kushner, B. H.; Modak, S.; LaQuaglia, M. P.; Wolden, S. L.; Basu, E. M.; Roberts, S. S.; Kramer, K.; Cheung, I. Y.; Cheung, N. K. V.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save